Michelangelo Fiorentino, Francesco Vasuri, Matteo Ravaioli, Lorenza Ridolfi, Walter Franco Grigioni, Antonio Daniele Pinna, Antonia D'Errico‐Grigioni – 24 November 2009 – Histological quality assessment of donated livers is a key factor for extending the cadaveric donor pool for liver transplantation. We retrospectively compared frozen‐section analysis with routine histological permanent slides and the outcomes of grafts in liver biopsies from 294 candidate donors.

Jorge Rakela, John F. Fung – 24 November 2009

Jie Ren, Ming‐De Lu, Rong‐Qin Zheng, Min‐Qiang Lu, Mei Liao, Yong‐Jiang Mao, Zhi‐Juan Zheng, Yan Lu – 24 November 2009 – The aim of this study was to determine the efficacy of contrast‐enhanced ultrasound for depicting the perfusion of hilar bile ducts in ischemic‐type biliary lesions after orthotopic liver transplantation. Thirteen transplant recipients with ischemic‐type biliary lesions and 12 patients without ischemic‐type biliary lesions underwent ultrasound examinations after the injection of 1.5 mL of an intravenous contrast agent.

John A. Stauffer, Jeffery L. Steers, Hugo Bonatti, Marjorie K. Dougherty, Jaime Aranda‐Michel, Rolland C. Dickson, Denise M. Harnois, Justin H. Nguyen – 24 November 2009 – Liver transplantation may occasionally be indicated in patients with unique clinical scenarios. Little is known regarding the outcomes of patients who have had a pancreatic resection prior to, in combination with, or after liver transplantation. A retrospective review of all patients undergoing liver transplantation from March 1998 to March 2008 identified 17 patients who also underwent pancreatic resection.

Zoe A. Stewart, Jayme E. Locke, Dorry L. Segev, Nabil N. Dagher, Andrew L. Singer, Robert A. Montgomery, Andrew M. Cameron – 24 November 2009 – Hepatic artery thrombosis (HAT) is the most common vascular complication after liver transplantation; it has been reported to occur in 2% to 5% of liver transplant recipients. Most reports of HAT in the literature describe single‐center series with small numbers of patients and lack the power to definitively identify nontechnical risk factors.

24 November 2009

24 November 2009

Tadafumi Asaoka, Tomoaki Kato, Shigeru Marubashi, Keizo Dono, Naoki Hama, Hidenori Takahashi, Shogo Kobayashi, Yutaka Takeda, Ichiro Takemasa, Hiroaki Nagano, Hideo Yoshida, Phillip Ruiz, Andreas G. Tzakis, Kenichi Matsubara, Morito Monden, Yuichiro Doki, Masaki Mori – 24 November 2009 – Histopathological evaluation of the liver via biopsy remains the standard procedure for the diagnosis of both acute cellular rejection (ACR) and recurrent hepatitis C (RHC) after liver transplantation.

Jacqueline G. O'Leary, Chet R. Rees, Göran B. Klintmalm, Gary L. Davis – 24 November 2009

Javier F. Castroagudín, Esther Molina, Rafael Romero, Esteban Otero, Santiago Tomé, Evaristo Varo – 24 November 2009 – Chronic renal dysfunction is a frequent and severe complication in solid‐organ transplant recipients. Calcineurin inhibitors (CNIs) are the main pathogenic factors of renal dysfunction. Switching from CNIs to nonnephrotoxic drugs, such as mammalian target of rapamycin inhibitors (everolimus and sirolimus), can improve renal function in these patients, but available data about the efficacy and safety of everolimus in liver transplant recipients are scarce.